393 related articles for article (PubMed ID: 10480216)
1. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
Boumpas DT; Tassiulas IO; Fleisher TA; Vaughan E; Piscitelli S; Kim Y; Pucino F; Balow JE; Austin HA
Clin Nephrol; 1999 Aug; 52(2):67-75. PubMed ID: 10480216
[TBL] [Abstract][Full Text] [Related]
2. High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.
Davis JC; Fessler BJ; Tassiulas IO; McInnes IB; Yarboro CH; Pillemer S; Wilder R; Fleisher TA; Klippel JH; Boumpas DT
J Rheumatol; 1998 Sep; 25(9):1694-704. PubMed ID: 9733448
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
Illei GG; Yarboro CH; Kuroiwa T; Schlimgen R; Austin HA; Tisdale JF; Chitkara P; Fleisher T; Klippel JH; Balow JE; Boumpas DT
Rheumatology (Oxford); 2007 Jun; 46(6):952-6. PubMed ID: 17317716
[TBL] [Abstract][Full Text] [Related]
4. A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures.
Adams EM; Pucino F; Yarboro C; Hicks JE; Thornton B; McGarvey C; Sonies BC; Bartlett ML; Villalba ML; Fleisher T; Plotz PH
J Rheumatol; 1999 Feb; 26(2):352-60. PubMed ID: 9972969
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
6. [Long-term administration of cyclosporine A in patients with IgA nephropathy].
Chábová V; Tesar V; Zabka J; Rychlík I; Merta M; Jirsa M; Stejskalová A; Stejskal J
Cas Lek Cesk; 1996 Dec; 135(24):803-6. PubMed ID: 9072300
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.
Haas M; Mayer G; Wirnsberger G; Holzer H; Ratschek M; Neyer U; Neuweiler J; Kramar R; Schneider B; Breiteneder-Geleff S; Regele HM; Hörl WH; Kerjaschki D
Wien Klin Wochenschr; 2002 Feb; 114(4):143-7. PubMed ID: 12060980
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine A in treatment of membranous lupus nephropathy.
Hu W; Liu Z; Shen S; Li S; Yao X; Chen H; Li L
Chin Med J (Engl); 2003 Dec; 116(12):1827-30. PubMed ID: 14687467
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW; Wetzels JF
Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
[TBL] [Abstract][Full Text] [Related]
10. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[TBL] [Abstract][Full Text] [Related]
11. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis.
Tang Z; Zhou H; Yao X; Hu W; Leishi L
Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.
Cattran DC; Delmore T; Roscoe J; Cole E; Cardella C; Charron R; Ritchie S
N Engl J Med; 1989 Jan; 320(4):210-5. PubMed ID: 2643046
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin A treatment for idiopathic membranous nephropathy.
Yao X; Chen H; Wang Q; Tang Z; Hu W; Yin G; Liu Z; Li L
Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine treatment of lupus membranous nephropathy.
Radhakrishnan J; Kunis CL; D'Agati V; Appel GB
Clin Nephrol; 1994 Sep; 42(3):147-54. PubMed ID: 7994932
[TBL] [Abstract][Full Text] [Related]
16. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
Hofstra JM; Branten AJ; Wirtz JJ; Noordzij TC; du Buf-Vereijken PW; Wetzels JF
Nephrol Dial Transplant; 2010 Jan; 25(1):129-36. PubMed ID: 19666912
[TBL] [Abstract][Full Text] [Related]
17. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW; Branten AJ; Wetzels JF;
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumour necrosis factor alpha in idiopathic membranous nephropathy: a pilot study.
Lionaki S; Siamopoulos K; Theodorou I; Papadimitraki E; Bertsias G; Boumpas D; Boletis J
Nephrol Dial Transplant; 2009 Jul; 24(7):2144-50. PubMed ID: 19202167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
